These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 8114756)

  • 1. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
    Pakdel F; Reese JC; Katzenellenbogen BS
    Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
    Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
    McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
    Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of wild type and mutant estrogen receptors on DNA flexibility, DNA bending, and transcription activation.
    Potthoff SJ; Romine LE; Nardulli AM
    Mol Endocrinol; 1996 Sep; 10(9):1095-106. PubMed ID: 8885244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.
    Katzenellenbogen BS; Fang H; Ince BA; Pakdel F; Reese JC; Wooge CH; Wrenn CK
    Breast Cancer Res Treat; 1993; 27(1-2):17-26. PubMed ID: 8260727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
    Cho H; Katzenellenbogen BS
    Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination.
    Pakdel F; Katzenellenbogen BS
    J Biol Chem; 1992 Feb; 267(5):3429-37. PubMed ID: 1737796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two cysteines closely positioned in the ligand-binding pocket of the human estrogen receptor: roles in ligand binding and transcriptional activation.
    Reese JC; Wooge CH; Katzenellenbogen BS
    Mol Endocrinol; 1992 Dec; 6(12):2160-6. PubMed ID: 1491695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands.
    Reese JC; Katzenellenbogen BS
    J Biol Chem; 1991 Jun; 266(17):10880-7. PubMed ID: 2040605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues.
    Petersen DN; Tkalcevic GT; Koza-Taylor PH; Turi TG; Brown TA
    Endocrinology; 1998 Mar; 139(3):1082-92. PubMed ID: 9492041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A triple mutant of the Drosophila ERR confers ligand-induced suppression of activity.
    Ostberg T; Jacobsson M; Attersand A; Mata de Urquiza A; Jendeberg L
    Biochemistry; 2003 Jun; 42(21):6427-35. PubMed ID: 12767224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor mutants which do not bind 17 beta-estradiol dimerize and bind to the estrogen response element in vivo.
    Zhuang Y; Katzenellenbogen BS; Shapiro DJ
    Mol Endocrinol; 1995 Apr; 9(4):457-66. PubMed ID: 7659089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a temperature-sensitive mutation in the hormone binding domain of the human estrogen receptor. Studies in cell extracts and intact cells and their implications for hormone-dependent transcriptional activation.
    Reese JC; Katzenellenbogen BS
    J Biol Chem; 1992 May; 267(14):9868-73. PubMed ID: 1577818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional synergy between the transcription factor Sp1 and the estrogen receptor.
    Porter W; Saville B; Hoivik D; Safe S
    Mol Endocrinol; 1997 Oct; 11(11):1569-80. PubMed ID: 9328340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.